Literature DB >> 17313486

A novel immunodeficiency characterized by the exclusive presence of transitional B cells unresponsive to CpG.

Alessandro Plebani1, Vassilios Lougaris, Annarosa Soresina, Antonella Meini, Federica Zunino, Claretta Gioia Losi, Roberta Gatta, Gemma Cattaneo, Luigi Nespoli, Maddalena Marinoni, Federica Capolunghi, Marina Vivarelli, Isabella Quinti, Rita Carsetti.   

Abstract

The objective of this study was to describe a novel form of primary immune disorder characterized by circulating B cells with the exclusive transitional phenotype which fail to respond to CpG stimulation. The 12-year-old male patient suffered from recurrent bacterial infections since infancy. The immunological studies were based on extensive B cell immunophenotyping, humoral in vivo response to different vaccine antigens, and in vitro proliferation and immunoglobulin production after CpG stimulation. Sequence analysis for potentially candidate genes such as IRF8, MyD88, TLR9, T-bet were performed. The patient's serum immunoglobulin levels and the specific antibody response to tetanus toxoid were normal, whereas that to polysaccharide antigens was severely impaired. Flow cytometric analysis showed that almost all patient's peripheral B cells had the transitional phenotype (CD24(bright) CD38(bright) CD27(neg)). Furthermore, the patient's B cells did not proliferate and failed to secrete immunoglobulins after in vitro CpG stimulation. Sequence analysis for TLR9, MyD88, IRF8 and T-bet showed no mutations. To our knowledge, this is the first case of a novel primary immunodeficiency mimicking the clinical phenotype of common variable immunodeficiency, with a peculiar immunological phenotype characterized by normal immunoglobulin serum levels, circulating B cells with the exclusive transitional phenotype unable to respond to CpG stimulation. This defines a novel form of primary immunodeficiency mimicking common variable immunodeficiency in the presence of normal immunoglobulin serum levels.

Entities:  

Mesh:

Year:  2007        PMID: 17313486      PMCID: PMC2265946          DOI: 10.1111/j.1365-2567.2006.02556.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  T-bet regulates T-independent IgG2a class switching.

Authors:  Andrea J Gerth; Ling Lin; Stanford L Peng
Journal:  Int Immunol       Date:  2003-08       Impact factor: 4.823

2.  TLR9 is localized in the endoplasmic reticulum prior to stimulation.

Authors:  Cynthia A Leifer; Margaret N Kennedy; Alessandra Mazzoni; ChangWoo Lee; Michael J Kruhlak; David M Segal
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

3.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Authors:  A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

4.  Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells.

Authors:  F Takeshita; C A Leifer; I Gursel; K J Ishii; S Takeshita; M Gursel; D M Klinman
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

5.  Mannose binding protein gene mutations associated with unusual and severe infections in adults.

Authors:  J A Summerfield; S Ryder; M Sumiya; M Thursz; A Gorchein; M A Monteil; M W Turner
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

6.  Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.

Authors:  D T Umetsu; D M Ambrosino; I Quinti; G R Siber; R S Geha
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

7.  CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.

Authors:  Ningshu Liu; Noriko Ohnishi; Lin Ni; Shizuo Akira; Kevin B Bacon
Journal:  Nat Immunol       Date:  2003-05-25       Impact factor: 25.606

Review 8.  Early defects in B cell development.

Authors:  Mary Ellen Conley
Journal:  Curr Opin Allergy Clin Immunol       Date:  2002-12

9.  Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Hee Jeong Kong; Akira Nishiyama; Ken J Ishii; Dennis M Klinman; Keiko Ozato
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

10.  Pyogenic bacterial infections in humans with IRAK-4 deficiency.

Authors:  Capucine Picard; Anne Puel; Marion Bonnet; Cheng-Lung Ku; Jacinta Bustamante; Kun Yang; Claire Soudais; Stéphanie Dupuis; Jacqueline Feinberg; Claire Fieschi; Carole Elbim; Remi Hitchcock; David Lammas; Graham Davies; Abdulaziz Al-Ghonaium; Hassan Al-Rayes; Sulaiman Al-Jumaah; Sami Al-Hajjar; Ibrahim Zaid Al-Mohsen; Husn H Frayha; Rajivi Rucker; Thomas R Hawn; Alan Aderem; Haysam Tufenkeji; Soichi Haraguchi; Noorbibi K Day; Robert A Good; Marie-Anne Gougerot-Pocidalo; Adrian Ozinsky; Jean-Laurent Casanova
Journal:  Science       Date:  2003-03-13       Impact factor: 47.728

View more
  7 in total

Review 1.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

2.  Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration.

Authors:  Isabella Quinti; Annarosa Soresina; Carlo Agostini; Giuseppe Spadaro; Andrea Matucci; Ifigeneia Sfika; Helene Martini; Federica Borghese; Andrea Guerra; Vultaggio Alessandra; Marcella Visentini; Alessandro Plebani; Massimo Fiorilli
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

Review 3.  Regulatory B cells in autoimmune diseases.

Authors:  Min Yang; Ke Rui; Shengjun Wang; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2013-01-07       Impact factor: 11.530

4.  Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.

Authors:  Xin Wei; Yangqiu Jin; Yinpu Tian; Huiyuan Zhang; Jie Wu; Wei Lu; Xiaofen Lu
Journal:  Tumour Biol       Date:  2015-12-05

Review 5.  Differential impact of Toll-like receptor signaling on distinct B cell subpopulations.

Authors:  Almut Meyer-Bahlburg; David J Rawlings
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

6.  B cell-associated immune profiles in patients with end-stage renal disease (ESRD).

Authors:  Kyoung Woon Kim; Byung Ha Chung; Eun Joo Jeon; Bo-Mi Kim; Bum Soon Choi; Cheol Whee Park; Yong-Soo Kim; Seok-Goo Cho; Mi-La Cho; Chul Woo Yang
Journal:  Exp Mol Med       Date:  2012-08-31       Impact factor: 8.718

7.  Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.

Authors:  Rita Carsetti; Francesco Corrente; Claudia Capponi; Mattia Mirabella; Simona Cascioli; Patrizia Palomba; Valentina Bertaina; Daria Pagliara; Manuela Colucci; Eva Piano Mortari
Journal:  Cytometry A       Date:  2021-12-01       Impact factor: 4.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.